Synthesis and Molecular Docking of Curcumin‐Derived Pyrazole‐Thiazole Hybrids as Potent α ‐Glucosidase Inhibitors
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202401766 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Jehan Y Al-Humaidi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Science, Princess Nourah bint Abdulrahman University, P.O. BOX 84428, Riyadh, 11671, Saudi Arabia. Hauptthemen laut MEDLINE: Pyrazoles, Molecular Docking Simulation, Glycoside Hydrolase Inhibitors, Thiazoles. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 83 Literaturangaben. Gefördert von: Deanship of Scientific Research at Princess Nourah bint Abdulrahman University, Deanship of Scientific Research, Princess Nourah Bint Abdulrahman University.
Abstract (Originalsprache)
α ‐Glucosidase inhibitors are critical for diabetes management, with pyrazoles and thiazoles emerging as effective options. This research highlights curcumin‐based pyrazole‐thiazole hybrids as potential inhibitors, synthesizing derivatives and evaluating their inhibitory capabilities. The study involved the synthesis of novel compounds using hydrazonoyl halides, confirmed through elemental and spectral analyses. The synthesized derivatives exhibited significant α ‐glucosidase inhibition, with IC 50 values ranging from 3.37±0.25 to 16.35±0.37 μM. Among them, compound 7e demonstrated the strongest inhibition at 3.37±0.25 μM, outperforming the standard drug acarbose (IC 50 =5.36±0.31 μM). In silico assessments and molecular docking using AutoDock Vina revealed strong interactions, particularly with compounds 7b , 7e , 7f , and 7g , indicating their potential as stable and effective inhibitors. The results suggest that the synthesized pyrazole‐thiazole hybrids hold promise as novel therapeutic agents for diabetes, warranting further exploration of their substituent effects for optimized inhibitor design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, College of Science, Princess Nourah bint Abdulrahman University, P.O. BOX 84428, Riyadh, 11671, Saudi Arabia.
- Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Matunga, Mumbai, 400019, India.
- Department of Chemistry, Faculty of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, 11623, Saudi Arabia.
- Department of Pharmaceutical Chemistry, Goa College of Pharmacy, Panaji Goa, 403001, India.
- Department of Physical Sciences, Chemistry Division, College of Science, Jazan University, P.O. Box. 114, Jazan, 45142, Kingdom of Saudi Arabia.
- Chemistry Department, Faculty of Science, Islamic University of Madinah, Madinah, 42351, Saudi Arabia.
ORCID-Profile: Deepika Maliwal, Raghuvir Pissurlenkar, Sobhi M Gomha
Förderung
- Deanship of Scientific Research at Princess Nourah bint Abdulrahman University
- Deanship of Scientific Research, Princess Nourah Bint Abdulrahman University
Zitieren
APA
Al-Humaidi, J. Y., Albedair, L. A., Maliwal, D., Zaki, M. E. A., Al-Hussain, S. A., Pissurlenkar, R., Mukhrish, Y. E., Abolibda, T. Z., & Gomha, S. M. (2025). Synthesis and Molecular Docking of Curcumin‐Derived Pyrazole‐Thiazole Hybrids as Potent α ‐Glucosidase Inhibitors. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202401766
Vancouver
Al-Humaidi JY, Albedair LA, Maliwal D, Zaki MEA, Al-Hussain SA, Pissurlenkar R, et al. Synthesis and Molecular Docking of Curcumin‐Derived Pyrazole‐Thiazole Hybrids as Potent α ‐Glucosidase Inhibitors. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202401766
BibTeX
@article{AlHumaidi2025,
author = {Al-Humaidi, Jehan Y and Albedair, Lamia A and Maliwal, Deepika and Zaki, Magdi E A and Al-Hussain, Sami A and Pissurlenkar, Raghuvir and Mukhrish, Yousef E and Abolibda, Tariq Z and Gomha, Sobhi M},
title = {Synthesis and Molecular Docking of Curcumin‐Derived Pyrazole‐Thiazole Hybrids as Potent α ‐Glucosidase Inhibitors},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202401766}
}
EUVIMED